Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05952752
Other study ID # dexemedetomidine on shivering
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 20, 2023
Est. completion date October 1, 2023

Study information

Verified date July 2023
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants will examine dexemedetomidine versus dexamethasone on postoperative shivering after spinal anesthesia for caesarean section


Description:

Patients and Methods Setting and ethics and trial registration The present randomized clinical study is planned to be conducted at Gynecology and Obstetrics Department, Assiut University Hospitals in the time from February through March, 2023. The study protocol will be approved by the independent institutional review board and all participants with provide informed consent prior to enrollment. The study will be registered at clinicaltrials.gov before recruitment of the first patient. Sample size calculation To detect a 20 % of differences between shivering scores in the studies groups, the sample size was calculated using a study power of 95.0 % and two-sided significance level of 5.0 % with 1:1 ratio. The estimated sample size for each group was 164 patients. We added 10 % of patients as expected dropout rate. So, the final sample size will be 191 patients per group. Sample size was calculated using G Power 3.1.6.9 (Kiel University, Germany). Patient recruitment The present study will include American Society of Anesthesiology (ASA) I-II women scheduled for elective CS under intrathecal anesthesia. Patients will be excluded if they had local infection, bleeding disorder or known allergy to any of the study medications. Randomization, blinding and allocation Patients in each study category will be equally and randomly assigned to receive either DEXA or DEXM using computer generated random tables and sealed envelopes. Independent researchers who aren't aware of the scope of the study will be assigned to assess and report patient outcome. Used medications will be prepared in similar packages to secure adequate blinding. Preoperative preparation, monitoring and anesthesia All patients will be instructed, prepared and monitored according the standard guidelines. Preoperative medications will include IV granisetron 1gm and ranitidine 50mg. Spinal anesthesia will be accomplished using 10-12 mg of 0.5% hyperbaric bupivacaine. When adequate level of anesthesia is guaranteed, CS is started under appropriate hemodynamic monitoring. Once the baby is delivered, 10 IV units of oxytocin will be administered. Study interventions Patients in the studied groups will receive either or intravenous DEXM 10 µg (Sween et al., 2021) or IV infusion of DEXA 8 mg (Esmat et al., 2021). Outcome assessment The primary outcome of the present study is the incidence of clinically significant postoperative shivering (Grade 2/3) assessed by 4-point scale (Badjatia et al., 2008) as follows: 1. None (Grade 0): no shivering noted on palpation of the masseter, neck, or chest wall 2. Mild (Grade 1): shivering localized to the neck and/ or thorax only 3. Moderate (Grade 2): shivering involved gross movement of the upper extremities (in addition to neck and thorax) 4. Severe (Grade 3): shivering involved gross movements of the trunk and upper and lower extremities Secondary outcome measures will be postoperative pain, hypotension, sedation grade, patient satisfaction, time to sensory and motor onset and time to use of first rescue analgesia. Statistical analysis All reported data will be recorded and statistically analyzed using appropriate statistical tests.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 382
Est. completion date October 1, 2023
Est. primary completion date September 25, 2023
Accepts healthy volunteers No
Gender Female
Age group 16 Years to 45 Years
Eligibility Inclusion Criteria: - Female - Pregnant full term - Undergoing Cesarean section - Spinal anesthesia Exclusion Criteria: - Patient refusal - General anesthesia - Contraindications for spinal anesthesia - Obstetric hemorrhagic complications as placenta accreta, previa, concealed hemorrhage - Hysterectomy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
giving dexemedetomidine 12 microgram Iv dripping
Patients in the studied groups will receive either or intravenous Dexemedetomidine 12 µg
Dexamethsone IV
4 mg IV dexamethasone

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Prevention of postoperative shivering according to bedside shivering assessment scale grade I: no shivering (score 0)
Grade II: localized to the neck or thorax mainly (score 1)
Grade III: moderate shivering including the gross length of upper extremeties(score2)
Grade IV:severe shivering including the gross movement of the trunk, upper and lower extremities( score 3)
till end of spinal anesthesia up to 6 hours
Secondary postoperative analgesia according to numerical rating scale( NRS) NRS score assessment in combination to time to first rescue of analgesia including score 1 with the least pain experienced in life and score 10 as the most painful experienced pain in life then the pain grading is in between 6 hours after induction of spinal anesthesia
See also
  Status Clinical Trial Phase
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Active, not recruiting NCT02965586 - Efficacy of Intrathecal Versus Intravenous Dexmedetomidine for Prevention of Post Spinal Anesthesia Shivering Phase 1/Phase 2
Completed NCT05427149 - The Effect of Intrathecal Magnesium Sulfate on Shivering N/A
Completed NCT04133961 - Intraoperative Phenylephrine Infusion to Reduce Postoperative Shivering in Lower Segment Caesarean Section N/A
Completed NCT06238739 - Optimal Temperature Control in Body Contouring Procedures N/A
Recruiting NCT04735965 - Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft Phase 4
Completed NCT01793558 - Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section N/A
Completed NCT05718011 - Prevention of Shivering After Spinal Anesthesia Phase 4
Recruiting NCT05342376 - Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering. Phase 4
Completed NCT02569905 - Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering Phase 4